Biblio Discovery — Demo Discovery Service

70 results for "Deming, Dustin A"

Showing 1–20 · 0.20 seconds · RSS

  1. Journal Article Full text

    Advances in immunotherapeutic strategies for colorectal cancer commentary on: tumoral immune cell exploitation in colorectal cancer metastases can be targeted effectively by anti-CCR5 therapy in cancer patients by Halama et al

    Deming, Dustin A.

    J Immunother Cancer · 2016 · English · PubMed Central

    Colorectal cancer is a leading cause of cancer-related death in the United States, despite recent advances in treatment strategies. The immune system has been implicated in the pathogenesis of colorectal cancer, with numerous studies identifying either antagonistic or pro-tumorigenic effects of…

  2. Journal Article Full text

    Primary and acquired resistance to biologic therapies in gastrointestinal cancers

    Lubner, Sam J.; Uboha, Nataliya V.; Deming, Dustin A.

    J Gastrointest Oncol · 2017 · English · PubMed Central

    Improvements in the understanding of cancer biology have led to therapeutic advances in the treatment of gastrointestinal cancers. Drugs which target the vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) pathways have led the way in colon cancer. Monoclonal…

  3. Journal Article Full text

    Technologies to Assess Drug Response and Heterogeneity in Patient-Derived Cancer Organoids

    Skala, Melissa C.; Deming, Dustin A.; Kratz, Jeremy D.

    Annu Rev Biomed Eng · 2022 · English · PubMed Central

    Patient-derived cancer organoids (PDCOs) are organotypic 3D cultures grown from patient tumor samples. PDCOs provide an exciting opportunity to study drug response and heterogeneity within and between patients and this research can guide new drug development and inform clinical treatment planning…

  4. Journal Article Full text

    Volumetric growth tracking of patient-derived cancer organoids using optical coherence tomography

    Gil, Daniel A.; Deming, Dustin A.; Skala, Melissa C.

    Biomed Opt Express · 2021 · English · PubMed Central

    Patient-derived cancer organoids (PCOs) are in vitro organotypic models that reflect in vivo drug response, thus PCOs are an accessible model for cancer drug screening in a clinically relevant timeframe. However, current methods to assess the response of PCOs are limited. Here, a custom…

  5. Journal Article Full text

    The Precision-Guided Use of PI3K Pathway Inhibitors for the Treatment of Solid Malignancies

    Schmitz, Alexa E.; Udgata, Shirsa; Johnson, Katherine A. et al.

    Biomedicines · 2025 · English · PubMed Central

    Phosphatidylinositol-3-kinase (PI3K)/AKT/mammalian target of rapamycin (MTOR) pathway hyperactivation is seen in a multitude of malignancies. Due to the importance of this pathway in numerous critical cellular functions, preclinical and clinical investigations have aimed to target this pathway as…

  6. Journal Article Full text

    Targeted Therapy in Metastatic Colorectal Cancer: Current Standards and Novel Agents in Review

    DeStefanis, Rebecca A.; Kratz, Jeremy D.; Emmerich, Philip B. et al.

    Curr Colorectal Cancer Rep · 2019 · English · PubMed Central

    PURPOSE OF REVIEW: Treatment options for patients with metastatic colorectal cancer continue to advance as the therapeutic implications of the molecular subtypes of this disease are becoming better understood. DNA sequencing and mismatch repair assessment are now standard of care analyses for…

  7. Journal Article Full text

    Breast cancer immunotherapy: current biomarkers and the potential of in vitro assays

    Skala, Melissa C.; Ayuso, Jose M.; Burkard, Mark E. et al.

    Curr Opin Biomed Eng · 2021 · English · PubMed Central

    Breakthroughs in metastatic breast cancer care require new model systems that can identify the unique features and vulnerabilities of each cancer. Primary tumor cultures are proposed to efficiently screen multiple treatment options in a patient-specific strategy to maximize therapeutic benefit…

  8. Journal Article Full text

    Genomic complexity in advanced gastric and esophageal adenocarcinomas: a case report of rare WDR11-AS1-FGFR2 fusions

    Mehlhaff, Eric; Deming, Dustin A.; Kratz, Jeremy D. et al.

    Front Oncol · 2025 · English · PubMed Central

    Fibroblast growth factor receptor 2 (FGFR2) alterations represent an emerging therapeutic target in gastroesophageal adenocarcinoma (GEA). Although FGFR2 amplifications and overexpression have been associated with poor prognosis and therapeutic resistance, the clinical significant FGFR2 fusions…

  9. Journal Article Full text

    Molecular Evolution of a Glioblastoma Controlled With Tumor Treating Fields and Concomitant Temozolomide

    Robins, H. Ian; Nguyen, HuyTram N.; Field, Aaron et al.

    Front Oncol · 2018 · English · PubMed Central

    Tumor Treating Field (TTFields) therapy has demonstrated efficacy in a Phase 3 study of newly diagnosed glioblastoma (GB) following radiation (RT) and temozolomide (TMZ). We report the appearance of an isolated satellite anterior temporal lobe lesion, 2 months post primary RT/TMZ directed at the…

  10. Journal Article Full text

    Novel Murine Pancreatic Tumor Model Demonstrates Immunotherapeutic Control of Tumor Progression by a Toxoplasma gondii Protein

    Payne, Susan N.; Emmerich, Philip B.; Davis, Nicole M. et al.

    Infect Immun · 2021 · English · PubMed Central

    Pancreatic ductal adenocarcinoma is the fourth leading cause of cancer-related death in the United States, with few effective treatments available and only 10% of those diagnosed surviving 5 years. Although immunotherapeutics is a growing field of study in cancer biology, there has been little…

  11. Journal Article Full text

    Inhibition of B-cell lymphoma 2 family proteins alters optical redox ratio, mitochondrial polarization, and cell energetics independent of cell state

    Gillette, Amani A.; DeStefanis, Rebecca A.; Pritzl, Stephanie L. et al.

    J Biomed Opt · 2022 · English · PubMed Central

    SIGNIFICANCE: The optical redox ratio (ORR) [autofluorescence intensity of the reduced form of nicotinamide adenine dinucleotide (phosphate) (NAD(P)H)/flavin adenine dinucleotide (FAD)] provides a label-free method to quantify cellular metabolism. However, it is unclear whether changes in the ORR…

  12. Journal Article Full text

    Label-free redox imaging of patient-derived organoids using selective plane illumination microscopy

    Favreau, Peter F.; He, Jiaye; Gil, Daniel A. et al.

    Biomed Opt Express · 2020 · English · PubMed Central

    High-throughput drug screening of patient-derived organoids offers an attractive platform to determine cancer treatment efficacy. Here, selective plane illumination microscopy (SPIM) was used to determine treatment response in organoids with endogenous fluorescence from the metabolic coenzymes…

  13. Journal Article Full text

    Molecular Profiles Guide Colorectal Cancer Treatment

    Kratz, Jeremy D.; Turk, Anita A.; Sievers, Chelsie K. et al.

    Fed Pract · 2016 · English · PubMed Central

    An improved understanding of colorectal cancer as a collection of multiple cancer subtypes is paving the way to precision medicine-based treatments.

  14. Journal Article Full text

    CT Texture Features of Liver Parenchyma for Predicting Development of Metastatic Disease and Overall Survival in Patients with Colorectal Cancer

    Lee, Scott J.; Zea, Ryan D.; Kim, David H. et al.

    Eur Radiol · 2017 · English · PubMed Central

    OBJECTIVES: To determine if identifiable hepatic textural features are present at abdominal CT in patients with colorectal cancer (CRC) prior to the development of CT-detectable hepatic metastases. METHODS: Four filtration-histogram texture features (standard deviation, skewness, entropy, and…

  15. Journal Article Full text

    Case report: Radiographic complete response of radiation-induced glioblastoma to front-line radiotherapy: A report and molecular characterization of two unique cases

    Grogan, Patrick T.; Helgager, Jeffrey J.; Deming, Dustin A. et al.

    Front Neurol · 2023 · English · PubMed Central

    Radiation-induced gliomas (RIGs) are an uncommon disease type and a known long-term complication of prior central nervous system radiation exposure, often during childhood. Given the rarity of this malignancy subtype, no clinical trials have explored optimal therapy for these patients, and the…

  16. Journal Article Full text

    Wide-Field Optical Redox Imaging with Leading-Edge Detection Enables Assessment of Treatment Response and Heterogeneity in Patient-Derived Cancer Organoids

    Gillette, Amani; Udgata, Shirsa; Schmitz, Alexa E. et al.

    Cancer Res · 2025 · English · PubMed Central

    Patient-derived cancer organoids (PDCO) are a valuable model to recapitulate human disease in culture, with important implications for drug development. However, current methods for rapidly and reproducibly assessing PDCOs are limited. Label-free imaging methods are a promising tool to measure…